In a human ‘challenge trial’ we deliberately infected volunteers with COVID to get the answer.
Articles on Challenge trial
Displaying all articles
At a secret location in London, volunteers will receive a COVID vaccine and subsequently be deliberately infected with the coronavirus.
Challenge trials – purposefully exposing volunteers to the coronavirus – could speed up the development of a vaccine. But there are serious ethical concerns with this approach.
There is a growing call for so-called challenge trials to speed up vaccine development.
Top contributors
-
Postdoc Research Fellow, Molecular and Cellular Biology, UCL
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Principal Research Fellow/Honorary consultant Respiratory Medicine, UCL
-
Lecturer in Philosophy, Fenner School of Environment and Society, Australian National University
-
Professor, Head of Institute for Ethics in Technology - TUHH, Technical University of Hamburg